Citation: Mb. Moller et al., Cyclin D3 expression in non-Hodgkin lymphoma - Correlation with other cellcycle regulators and clinical features, AM J CLIN P, 115(3), 2001, pp. 404-412
Authors:
Brincker, H
Pedersen, NT
Bendix-Hansen, K
Johansen, P
Citation: H. Brincker et al., Non-Hodgkin's lymphoma subtypes over time in an unselected population of 646 patients: a study of clinico-pathological data and incidence based on a review using the REAL-classification, LEUK LYMPH, 39(5-6), 2000, pp. 531-541
Authors:
Moller, MB
Kania, PW
Ino, Y
Gerdes, AM
Nielsen, O
Louis, DN
Skjodt, K
Pedersen, NT
Citation: Mb. Moller et al., Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16(INK4A), LEUKEMIA, 14(5), 2000, pp. 898-904
Authors:
Moller, MB
Gerdes, AM
Skjodt, K
Mortensen, LS
Pedersen, NT
Citation: Mb. Moller et al., Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma, CLIN CANC R, 5(5), 1999, pp. 1085-1091
Citation: Mb. Moller et al., Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities, MOD PATHOL, 12(11), 1999, pp. 1010-1016
Authors:
Moller, MB
Ino, Y
Gerdes, AM
Skjodt, K
Louis, DN
Pedersen, NT
Citation: Mb. Moller et al., Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma, LEUKEMIA, 13(3), 1999, pp. 453-459
Authors:
Pedersen, RK
Sorensen, AG
Pedersen, NT
Schmidt, KG
Kerndrup, GB
Citation: Rk. Pedersen et al., Chromosome aberrations in adult Hodgkin disease in a Danish population-based study, CANC GENET, 110(2), 1999, pp. 128-132
Authors:
Moller, MB
Skjodt, K
Mortensen, LS
Pedersen, NT
Citation: Mb. Moller et al., Clinical significance of cyclin-dependent kinase inhibitor p27(Kip1) expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27(Kip1), BR J HAEM, 105(3), 1999, pp. 730-736